Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director | July 16, 2019 | July 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date July 16, 2019 · Filed July 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 103,939 |
Last balance in matching sequence
After 2019-07-18 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2019-07-16 · Sale · Disposed 22,738 · Balance 197,653 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.88. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Row 2 · 2019-07-17 · Sale · Disposed 53,964 · Balance 143,689 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.755. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Row 3 · 2019-07-18 · Sale · Disposed 39,750 · Balance 103,939 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.88. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.755. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.50 to $68.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2018 Filed Jan 16, 2019 23:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 67,432 | $50.13 | $3,380,608.92 |
DisclosureSEC source: 0001213900-19-000817 · ownership.xml · nonDerivative · entry 6 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,196,339 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.23 to $51.26. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 16, 2018 Filed Jan 16, 2019 23:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 30,704 | $50.83 | $1,560,546.15 |
DisclosureSEC source: 0001213900-19-000817 · ownership.xml · nonDerivative · entry 5 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,263,771 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.455 to $51.435. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 15, 2018 Filed Jan 16, 2019 23:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 22,568 | $49.27 | $1,111,889.25 |
DisclosureSEC source: 0001213900-19-000817 · ownership.xml · nonDerivative · entry 4 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,294,475 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.945 to $49.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 15, 2018 Filed Jan 16, 2019 23:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 90,000 | $48.82 | $4,393,584.00 |
DisclosureSEC source: 0001213900-19-000817 · ownership.xml · nonDerivative · entry 3 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,317,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.11 to $49.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 15, 2018 Filed Jan 16, 2019 23:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 2,000 | $48.03 | $96,053.80 |
DisclosureSEC source: 0001213900-19-000817 · ownership.xml · nonDerivative · entry 2 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,407,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.11 to $48.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| January 14, 2018 Filed Jan 16, 2019 23:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 88,000 | $48.69 | $4,284,420.80 |
DisclosureSEC source: 0001213900-19-000817 · ownership.xml · nonDerivative · entry 1 Erony Joyce · CIK 0001459212 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,409,043 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on December 10, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.515 to $49.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. The reporting person disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein. Read SEC document |
| May 02, 2015 Filed May 10, 2018 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (right to buy) · Derivative | 17,296 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031860 · a4.xml · derivative · entry 4 Erony Joyce · CIK 0001459212 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,296 Underlying: Common Stock · 17,296 shares Expires 2028-05-02 F3 · derivative.exercise_date: The option vests and becomes exercisable on May 2, 2019, subject to the Reporting Person's continuous service to the Issuer through such date. The option was erroneously included on the Reporting Person's Form 3 filed on May 2, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.